Navigation Links
Patient Safety Technologies Reports Second Quarter 2012 Results
Date:8/10/2012

revenue from filling a $10 million Forward Order to our exclusive distributor, Cardinal Health.  There was no revenue reported from the delivery of Forward Order inventory during the second quarter of 2012.  Excluding the effect of the Forward Order on reported second quarter 2011 revenue, second quarter 2012 Normalized Revenue (a non-GAAP measure defined below) year over year growth was 108%.

Reported operating expenses totaled $2.4 million for the second quarter of 2012, an increase of $0.7 million compared to $1.7 million of operating expenses during the same period in 2011. The increase in operating expenses was primarily due to higher one-time costs associated with the 65 successful new customer implementations during the second quarter of 2012 as compared to 3 implementations during the second quarter of 2011.  Total estimated one-time implementation costs in the second quarter of 2012 were approximately $0.5 million, as compared to a relatively negligible amount during the second quarter of 2011.During the second quarter of 2012 the Company generated positive Adjusted Operating Income (a non-GAAP measure defined below) of $0.2 million and a GAAP operating loss of $0.5 million.  This compares with an Adjusted Operating Loss of $0.3 million and a GAAP operating loss of $0.4 million generated during the second quarter of 2011.  The primary reasons for reporting positive Adjusted Operating Income during the second quarter of 2012 as compared to an Adjusted Operating Loss during the comparable prior year period was higher reported revenues associated with the significantly larger number of customer facilities during the second quarter of 2012 versus the prior year quarter, partially offset by the higher one-time implementation expenses.

"During the second quarter of 2012 we further accelerated the strong growth we began during the first quarter, once again implementing our solution in more new facilities than in any p
'/>"/>

SOURCE Patient Safety Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Watching, Reading and Listening: A New Way to Interact with Patient Information
4. Phreesia identifies over 26% of patients who require additional autism evaluation
5. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
8. New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinsons disease
9. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
10. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
11. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... 13, 2014 Auf ... Tokio veranstalteten F&E-Tagung meldete Astellas ... Neuausrichtung seines Forschungsrahmenprogramms. Die Tagung bot Astellas ... fortgeschrittenen klinischen Programme und die Konzernstrategie des ... bestand darin, aktuelle Meldungen zu den Astellas-Initiativen ...
(Date:7/13/2014)... 2014  Eli Lilly and Company (NYSE: ... non-clinical study in genetically engineered mice examining combination ... antibody N3pG and beta-secretase inhibitor BACE (LY2811376). Data ... in removing clumps of amyloid-beta protein in the ... lead to Alzheimer,s disease (AD) – than use ...
(Date:7/11/2014)... ANGELES , July 11, 2014 /PRNewswire-iReach/ -- ... e-liquid, a vegetable-glycol solution for use in portable ... of the active ingredients in cannabis, cannabidiol offers ... personal vaporizer devices, and other vaporizer technology. ... Cannabis naturally contains 483 different compounds which ...
Breaking Medicine Technology:Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 2Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 3Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 4New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2
... Neurocrine Biosciences,Inc. (Nasdaq: NBIX ) today announced its financial ... quarter of 2008, the Company reported a,net loss of $21.1 ... of,$25.7 million, or $(0.68) per share, for the same period ... were $1.8 million compared with,$0.1 million for the same period ...
... April 30 CureDM, Inc., a,biopharmaceutical company developing ... 1 and 2 diabetes, announces its,achievement of a ... CureDM has successfully stabilized HIP to improve its,bioavailability ... used in man may be as much as ...
Cached Medicine Technology:Neurocrine Biosciences Reports First Quarter 2008 Results 2Neurocrine Biosciences Reports First Quarter 2008 Results 3Neurocrine Biosciences Reports First Quarter 2008 Results 4Neurocrine Biosciences Reports First Quarter 2008 Results 5Neurocrine Biosciences Reports First Quarter 2008 Results 6Neurocrine Biosciences Reports First Quarter 2008 Results 7Neurocrine Biosciences Reports First Quarter 2008 Results 8CureDM's Diabetes Therapy Achieves Major Development Milestone 2
(Date:7/13/2014)... 13, 2014 Intraocular Lens (IOL) Market: ... 2013 - 2019 , Intraocular lens (IOL) is inserted ... or cataracts. The lenses are inserted inside the eye, ... intraocular lens replaces the focusing power of natural lens. ... lens to deliver the light focusing function which was ...
(Date:7/13/2014)... 13, 2014 Victorian Hotel has recently ... the rental of bikes for its "Cycle the City" ... Hotel to tour the area using a rental bicycle, ... enthusiasts love to call Vancouver home, as it is ... travel and picturesque journeys through the countryside. Vancouver hotel ...
(Date:7/13/2014)... additives are chemicals, which are added to various fuels ... on, in order to enhance their performance. Fuel additives ... by fuels and improving the combustion properties of fuels. ... scale in the long run, but, in the short ... products. , The various fuel additive types include deposit ...
(Date:7/13/2014)... Houston, TX (PRWEB) July 13, 2014 The ... for children ranging in age from four months to 12 ... skills and karate classes to birthday parties and Summer Camps, ... the Little Gym of Pearland after spending over ... variety of roles, including Gym Director. , Berry has ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 Recently, MyDressCity.com, ... and women’s special occasion outfits, has released its new ... all the new products are available at discounted prices. ... 26, 2014. , In the company’s online shop, ... all of them are made with great materials. MyDressCity.com’s ...
Breaking Medicine News(10 mins):Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Intraocular Lens (IOL) Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Victorian Hotel Creates Excitement by Adding "Cycle the City" Bike Rentals for Its Vancouver Hotel Rooms 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2Health News:Cheap Elegant Quinceanera Dresses Unveiled by MyDressCity.com 2
... temperatures could limit deaths from heat stroke, study says ... dry air under a football player,s uniform may prevent ... the cool air between a player and his pads ... to the findings, which are expected to be presented ...
... to Get More for Less, AUSTIN, Texas, July ... leading natural and organic foods supermarket,announced today the launch ... money-saving coupons and tips, and,budget recipes to help shoppers ... their food dollar. The Company has also,created a space ...
... July 10 SectorWatch.biz announces the,availability of MarketStats ... markets today. MarketStats offers a perspective on the,aforementioned ... with,articles and opinions on the subject and sector ... can view MarketStats by visiting: http://www.SectorWatch.biz ,-- ...
... 10 Reflecting the,continuing commitment of America,s ... and practices that best serve,the needs of ... and Manufacturers of America (PhRMA) Board of ... Code on Interactions with Healthcare,Professionals., The ...
... and PLANO, Texas, July 10 In the ... soon become heated with the,arrival of the newest ... market. Anika Therapeutics, FDA-approved ELEVESS(TM) enters the,arena with ... their,hyaluronic acid (H.A.) gel, to improve injection comfort., ...
... Bioniche Life Sciences,Inc. (TSX: BNC), a research-based, ... E. coli O157:H7,cattle vaccine at the XXV ... presentation was made by Dr. Dragan Rogan, ... was entitled,"Vaccination of Cattle with E. coli ...
Cached Medicine News:Health News:Cool Air Blown Under Pads May Protect Footballers From Illness 2Health News:Whole Foods Market(R) Launches 'The Real Deal' Program With Budget Recipes, Real Steals and Smart Shopping Advice 2Health News:Whole Foods Market(R) Launches 'The Real Deal' Program With Budget Recipes, Real Steals and Smart Shopping Advice 3Health News:SectorWatch.biz Issues MarketStats on Healthy Living Companies UKMA, LULU, GAIA, NTRI, and WTW 2Health News:PhRMA Revised Marketing Code Reinforces Commitment to Responsible Interactions With Healthcare Professionals 2Health News:PhRMA Revised Marketing Code Reinforces Commitment to Responsible Interactions With Healthcare Professionals 3Health News:PhRMA Revised Marketing Code Reinforces Commitment to Responsible Interactions With Healthcare Professionals 4Health News:Latest Hyaluronic Acid Filler Takes the Sting Out of Beauty 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary 2Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary 3Health News:Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary 4
Pipetman P is a fully adjustable, air-displacement pipette with the selected volume shown on a digital indicator (volumeter). Eight models cover the full range of volumes from 0.2 L to 10 mL....
... Finnpipette Digital offers improved ergonomics for ... handle, modified grippy finger rest and ... comfort and efficiency. Finnpipette Digitals also ... gearing mechanism (pat. pend.) and super ...
Research Series 2100 Adjustable-volume Pipette,100-1,000 l, single-channel with adjustable-volume setting...
... The Sysmex pocH-100i is the first ... with low daily testing requirements. With its ... 3-part differential from just 15 L of ... for any small healthcare site including the ...
Medicine Products: